Search Results - "JEPPESEN, P. B"

Refine Results
  1. 1

    Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome by Jeppesen, P B, Gilroy, R, Pertkiewicz, M, Allard, J P, Messing, B, O'Keefe, S J

    Published in Gut (01-07-2011)
    “…Teduglutide, a GLP-2 analogue, may restore intestinal structural and functional integrity by promoting repair and growth of the mucosa and reducing gastric…”
    Get more information
    Journal Article
  2. 2

    Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells by Bhattacharya, S., Oksbjerg, N., Young, J. F., Jeppesen, P. B.

    Published in Diabetes, obesity & metabolism (01-07-2014)
    “…Aims Caffeic acid, naringenin and quercetin are naturally occurring phenolic compounds (PCs) present in many plants as secondary metabolites. The aim of this…”
    Get full text
    Journal Article
  3. 3

    Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide – Analyses from a randomised, placebo-controlled study by Jeppesen, P.B, Pertkiewicz, M, Forbes, A, Pironi, L, Gabe, S.M, Joly, F, Messing, B, Loth, S, Youssef, N.N, Heinze, H, Berghöfer, P

    Published in Clinical nutrition (Edinburgh, Scotland) (01-10-2013)
    “…Summary Background & aims Short bowel syndrome (SBS)-intestinal failure (IF) patients have impaired quality of life (QoL) and suffer from the burden of…”
    Get full text
    Journal Article
  4. 4

    European Society of Coloproctology consensus on the surgical management of intestinal failure in adults by Vaizey, C. J., Maeda, Y., Barbosa, E., Bozzetti, F., Calvo, J., Irtun, Ø., Jeppesen, P. B., Klek, S., Panisic-Sekeljic, M., Papaconstantinou, I., Pascher, A., Panis, Y., Wallace, W. D., Carlson, G., Boermeester, M.

    Published in Colorectal disease (01-06-2016)
    “…Intestinal failure (IF) is a debilitating condition of inadequate nutrition due to an anatomical and/or physiological deficit of the intestine. Surgical…”
    Get full text
    Journal Article
  5. 5

    Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL™) scale by Berghöfer, P, Fragkos, K.C, Baxter, J.P, Forbes, A, Joly, F, Heinze, H, Loth, S, Pertkiewicz, M, Messing, B, Jeppesen, P.B

    Published in Clinical nutrition (Edinburgh, Scotland) (01-10-2013)
    “…Summary Background & aims Subjects with short bowel syndrome (SBS) have impaired quality of life (QoL). No disease-specific instrument has been available to…”
    Get full text
    Journal Article
  6. 6

    Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients by Jeppesen, P B, Sanguinetti, E L, Buchman, A, Howard, L, Scolapio, J S, Ziegler, T R, Gregory, J, Tappenden, K A, Holst, J, Mortensen, P B

    Published in Gut (01-09-2005)
    “…Background and aims: Glucagon-like peptide 2 (GLP-2) may improve intestinal absorption in short bowel syndrome (SBS) patients with an end jejunostomy…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat by Jeppesen, P.B., Gregersen, S., Rolfsen, S.E.D., Jepsen, M., Colombo, M., Agger, A., Xiao, J., Kruhøffer, M., Ørntoft, T., Hermansen, K.

    Published in Metabolism, clinical and experimental (01-03-2003)
    “…Stevioside, a glycoside present in the leaves of the plant, Stevia rebaudiana Bertoni (SrB), has acute insulinotropic effects in vitro. Its potential…”
    Get full text
    Journal Article
  9. 9

    Randomised controlled trial of colostrum to improve intestinal function in patients with short bowel syndrome by Lund, P, Sangild, P T, Aunsholt, L, Hartmann, B, Holst, J J, Mortensen, J, Mortensen, P B, Jeppesen, P B

    Published in European journal of clinical nutrition (01-09-2012)
    “…Background/Objectives: Colostrum is rich in immunoregulatory, antimicrobial and trophic components supporting intestinal development and function in newborns…”
    Get full text
    Journal Article
  10. 10

    Stevioside acts directly on pancreatic β cells to secrete insulin : Actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity by JEPPESEN, P. B, GREGERSEN, S, POULSEN, C. R, HERMANSEN, K

    Published in Metabolism, clinical and experimental (01-02-2000)
    “…The natural sweetener stevioside, which is found in the plant Stevia rebaudiana Bertoni, has been used for many years in the treatment of diabetes among…”
    Get full text
    Journal Article
  11. 11

    Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study by Szkudlarek, J, Jeppesen, P B, Mortensen, P B

    Published in Gut (01-08-2000)
    “…BACKGROUND High dose growth hormone, glutamine, and a high carbohydrate diet may improve intestinal function in short bowel patients. AIMS To investigate if…”
    Get full text
    Journal Article
  12. 12

    Quality of life in patients receiving home parenteral nutrition by Jeppesen, P B, Langholz, E, Mortensen, P B

    Published in Gut (01-06-1999)
    “…BACKGROUND/AIMS Quality of life is an important determinant of the effectiveness of health technologies, but it has rarely been assessed in patients receiving…”
    Get full text
    Journal Article
  13. 13

    Intestinal failure defined by measurements of intestinal energy and wet weight absorption by Jeppesen, P B, Mortensen, P B

    Published in Gut (01-05-2000)
    “…BACKGROUND AND AIMS Intestinal failure defined by the minimal energy and wet weight absorption required to avoid home parenteral nutrition (HPN) is not well…”
    Get full text
    Journal Article
  14. 14

    Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon by Jeppesen, P B, Hartmann, B, Thulesen, J, Hansen, B S, Holst, J J, Poulsen, S S, Mortensen, P B

    Published in Gut (01-09-2000)
    “…BACKGROUND The glucagon-like peptides (GLP) 1 and 2 are secreted postprandially from L cells located mainly in the ileum. Both hormones prolong intestinal…”
    Get full text
    Journal Article
  15. 15

    The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection by Jeppesen, P B, Mortensen, P B

    Published in Gut (01-10-1998)
    “…Background—Medium chain C8–C10 triglycerides (MCTs) improve fat absorption in short bowel patients. Effects on overall energy absorption remain unknown…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Clinical significance of GLP-2 in short-bowel syndrome by Jeppesen, P B

    Published in The Journal of nutrition (01-11-2003)
    “…Although long-term parenteral nutrition is lifesaving in patients with intestinal failure, it is expensive, severely impairs the quality of life in the…”
    Get more information
    Journal Article
  18. 18

    Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection by Haderslev, K V, Jeppesen, P B, Sorensen, H A, Mortensen, P B, Staun, M

    Published in Gut (01-05-2003)
    “…Background and aims: Vitamin D deficiency is common in patients with small intestinal resection and may lead to secondary hypersecretion of parathyroid hormone…”
    Get full text
    Journal Article
  19. 19

    Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure by Jeppesen, P B, Hartmann, B, Hansen, B S, Thulesen, J, Holst, J J, Mortensen, P B

    Published in Gut (01-10-1999)
    “…BACKGROUND Glucagon-like peptide 2 (GLP-2) is a growth factor for the intestinal epithelium in rodents and may affect intestinal transit. AIMS To study the…”
    Get full text
    Journal Article
  20. 20

    Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection by Jeppesen, P B, Staun, M, Tjellesen, L, Mortensen, P B

    Published in Gut (01-12-1998)
    “…Background—H2 receptor blockers and proton pump inhibitors reduce intestinal output in patients with short bowel syndrome. Aims—To evaluate the effect of…”
    Get full text
    Journal Article